International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Accepted/In Press date: 20 October 2021

e-pub ahead of print date: 5 January 2022

Published date: 11 February 2022

Additional Information: Funding Information: We would like to acknowledge the Global Pneumococcal Sequencing project (GPS) and other pneumococcal sequencing projects performed at the Wellcome Sanger Institute whose genomes were screened to identify isolates that could provide context for this analysis, and the Wellcome Sanger Institute Pathogen Informatics Team. The GPS data was supported by the Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. Furthermore, we acknowledge Lene Kolstad, Martha Bjørnstad and Nadia Debech of the Norwegian Institute of Public Health for the analysis of the Norwegian isolates, Brita A Winje for the Norwegian IPD surveillance data and the rest of the outbreak team for their work during the outbreak. We would like to acknowledge Anni Vainio, Milla Hietikko, Elina Yamazaki and Riitta Pulkkinen for laboratory and sequencing work of the Finnish isolates and the outbreak investigation team for their work to control the outbreak. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Sequencing of outbreak and contemporary IPD surveillance isolates were funded internally in the respective public health institutes. The Global Pneumococcal Sequencing project was funded by Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. J.C. was funded by the European Research Council grant no. 742158. PT is funded by the Wellcome Trust (Thailand-Laos AAP core award, grant no. 220211). Funding Information: We would like to acknowledge the Global Pneumococcal Sequencing project (GPS) and other pneumococcal sequencing projects performed at the Wellcome Sanger Institute whose genomes were screened to identify isolates that could provide context for this analysis, and the Wellcome Sanger Institute Pathogen Informatics Team. The GPS data was supported by the Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. Furthermore, we acknowledge Lene Kolstad, Martha Bjørnstad and Nadia Debech of the Norwegian Institute of Public Health for the analysis of the Norwegian isolates, Brita A Winje for the Norwegian IPD surveillance data and the rest of the outbreak team for their work during the outbreak. Funding Information: Sequencing of outbreak and contemporary IPD surveillance isolates were funded internally in the respective public health institutes. The Global Pneumococcal Sequencing project was funded by Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. J.C. was funded by the European Research Council grant no. 742158. PT is funded by the Wellcome Trust (Thailand-Laos AAP core award, grant no. 220211). Publisher Copyright: © 2021 The Author(s)

Keywords: Molecular epidemiology, Outbreak, PCVs, PPV23, Pneumococcal, ST801, Serotype 4, Streptococcus pneumoniae, Whole genome sequencing

Local EPrints ID: 454389

URI: http://eprints.soton.ac.uk/id/eprint/454389

DOI: doi:10.1016/j.vaccine.2021.10.046

ISSN: 0264-410X

PURE UUID: 83aae3f4-d37e-4342-8808-baacac5fcc06

ORCID for S C Clarke: orcid.org/0000-0002-7009-1548

Date deposited: 08 Feb 2022 17:47

Last modified: 06 Jun 2024 04:22